CTS Corporation (CTS) Market Cap & Valuation Ratios
CTS Corporation (CTS) has a market cap of $1.5B, a trailing P/E of 22.3 and a price-to-sales ratio of 2.7, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CTSCTS CorporationFollow CTS — free
—
Price chart with a free account
- Market cap
- 1.5B
- P/E TTM
- 22.3
- Dividend yield
- 0.3%
- 52-week
- —
- Next earnings
- 27 Oct, in 3 days
Peers
electronic components · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| CTS | 1.5 | 22.3 | 2.6 | 11.5 | 6.0% | +9% | 16% | 13% |
| OSIS | 3.1 | 21.9 | 2.1 | 14.5 | 7.2% | +4% | 12% | 13% |
| BELFB | 2.9 | 33.7 | 3.5 | 17.8 | 2.5% | +25% | 16% | 17% |
| KN | 2.7 | 41.8 | 4.5 | 21.9 | — | +13% | 15% | 10% |
| BHE | 2.4 | 45.1 | 0.8 | 15.5 | 5.2% | +9% | 3% | 6% |
| ROG | 2.2 | 72.7 | 2.4 | 18.7 | 3.7% | +5% | 6% | 3% |
| OUST | 2.1 | — | 9.2 | — | -3.9% | +63% | -31% | -29% |
| ALNT | 1.5 | 51.6 | 2.8 | 22.0 | 1.8% | +11% | 8% | 9% |
| DAKT | 1.0 | 21.0 | 1.0 | 10.4 | 4.0% | +14% | 7% | 30% |
| LYTS | 0.8 | 30.3 | 1.4 | 18.1 | 5.2% | +20% | 6% | 6% |
| KOPN | 0.6 | — | 13.8 | — | -2.9% | -7% | -23% | -23% |
| Median of these 10 | 37.7 | 2.6 | 17.9 | 3.7% | +12% | 7% | 7% |
P/E 22.3 vs. a peer median of 37.7; EV/Sales 2.6 vs. 2.6. CTS's own P/E sits at the 24th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesOUST and KOPN have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
CTS Corporation — questions
- What is CTS Corporation's market cap?
- $1.5B.
- What is CTS Corporation's P/E ratio?
- 22.3 on trailing twelve-month earnings to 2026-06-30.
- What is CTS Corporation's price-to-sales ratio?
- 2.7.
Every figure on this page comes from CTS Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.